Publication:

Low-loss hybrid polymer waveguide neural probes for visible-wavelength optical neuromodulation

Date

 
cris.virtual.department#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtual.department#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtual.department#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtual.orcid0000-0003-2102-6747
cris.virtual.orcid0000-0002-1338-9073
cris.virtual.orcid0000-0002-3470-620X
cris.virtualsource.department24d7c587-8df3-4b05-98b0-0329358c77c8
cris.virtualsource.department6b33ddf8-ec7d-44f1-8129-af55eaa7b1e6
cris.virtualsource.department9b42d0bc-60bf-45a2-a3b2-a257fa194a38
cris.virtualsource.orcid24d7c587-8df3-4b05-98b0-0329358c77c8
cris.virtualsource.orcid6b33ddf8-ec7d-44f1-8129-af55eaa7b1e6
cris.virtualsource.orcid9b42d0bc-60bf-45a2-a3b2-a257fa194a38
dc.contributor.authorPazzaglia, Federico
dc.contributor.authorVan Lysebettens, Wouter
dc.contributor.authorBabych, Anastasiia
dc.contributor.authorParys, Axel
dc.contributor.authorVan Vlierberghe, Sandra
dc.contributor.authorRaedt, Robrecht
dc.contributor.authorMissinne, Jeroen
dc.date.accessioned2026-11-05T08:45:49Z
dc.date.available2026-11-05T08:45:49Z
dc.date.createdwos2026
dc.date.issued2026
dc.description.abstractOptical neuromodulation techniques, including optogenetics and optopharmacology, offer promising clinical potential for epilepsy and neurodegenerative disorders. These methods require light delivery to deep brain regions via implantable probes, but chronic in vivo use faces challenges in biocompatibility, optical efficiency, and scalability. Conventional probes with integrated light sources or silica fibers ensure power delivery but are bulky and rigid, provoking foreign body responses. Flexible biocompatible probes improve tissue integration yet compromise optical performance. We introduce a waveguide-based probe using hybrid polymers fabricated with standard microfabrication methods. This probe achieves low propagation loss (<0.25 dB/cm across the visible spectrum) while balancing mechanical properties—soft yet stiff enough for direct implantation (Young’s modulus 1 GPa). In vivo tests in rats confirmed stable implantation and functionality for six weeks, demonstrating light-triggered seizure modulation.
dc.description.wosFundingTextWe would like to express our sincere gratitude to all the collegues of the 'Support Team' for their valuable technical contributions, insightful discussions, and continuous assistance. This work was financially supported by BOF-GOA project SOFTRESET (grant 01G02722) and FWO project (grant G075224N) "Uncaging the potential of photopharmacology for the treatment of epilepsy". Animals were treated according to the guidelines approved by the European Ethics Committee (decree86/609/EEC). The study protocol was approved by the Animal Experimental Committee of Ghent UniversityHospital (ECD 22-39).
dc.identifier.doi10.1117/12.3106028
dc.identifier.isbn979-8-9023-2149-1
dc.identifier.issn0277-786X
dc.identifier.urihttps://imec-publications.be/handle/20.500.12860/60731
dc.language.isoeng
dc.provenance.editstepusergreet.vanhoof@imec.be
dc.publisherSPIE-INT SOC OPTICAL ENGINEERING
dc.source.beginpage1409509
dc.source.conferenceNEUROPHOTONICS III
dc.source.conferencedate2026-04-12
dc.source.conferencelocationStrasbourg
dc.source.journalNEUROPHOTONICS III
dc.source.numberofpages6
dc.title

Low-loss hybrid polymer waveguide neural probes for visible-wavelength optical neuromodulation

dc.typeProceedings paper
dspace.entity.typePublication
imec.internal.crawledAt2026-09-07
imec.internal.sourcecrawler
imec.internal.wosCreatedAt2026-09-07
Files
Publication available in collections: